Expert Urological Care & Minimally Invasive MIST Center in Seoul
Medical Guide
Comparing UroLift, Rezum, and iTind for BPH in Seoul
UroLift, Rezum, and iTind are minimally invasive BPH options compared by mechanism, anatomy, recovery, and durability at Straight Urology Clinic, Seoul.
Schedule a ConsultationComparing UroLift, Rezum, and iTind for BPH in Seoul
Medically reviewed by Dr. Donghyun Lee, MOHW Board-Certified Urologist, Chief Director, Straight Urology Clinic
UroLift, Rezūm, and iTind are three minimally invasive procedures used to relieve the urinary symptoms of benign prostatic hyperplasia (BPH), each working through a different mechanism and suited to a different prostate anatomy. UroLift lifts and holds enlarged tissue out of the way with small implants, Rezūm uses water vapor to shrink obstructing tissue, and iTind temporarily reshapes the bladder neck and prostatic urethra before being removed. Straight Urology Clinic in Seoul, led by Dr. Donghyun Lee, an MOHW board-certified urologist, lists all three among its options. This article compares how they work, which anatomy each suits, what recovery looks like, and their honest limitations, so you can have a more informed conversation about which, if any, fits your situation.
What Is BPH, and Why Do Minimally Invasive Options Exist?
Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate gland that becomes more common with age. As the prostate grows, it can squeeze the urethra, the tube that carries urine out of the body, producing lower urinary tract symptoms such as a weak stream, difficulty starting, frequent urination, waking at night to urinate, and a sense of incomplete emptying. According to the National Institute of Diabetes and Digestive and Kidney Diseases, symptoms do not always match prostate size, and the condition is managed with watchful waiting, medications, or procedures depending on how much it affects quality of life.
For many years, the main surgical treatment was transurethral resection of the prostate (TURP), which removes obstructing tissue and remains an established comparator. Minimally invasive surgical therapies, often abbreviated MIST, were developed to relieve symptoms with less tissue removal, less anesthesia, and in many cases a lower risk of certain side effects such as ejaculatory changes. UroLift, Rezūm, and iTind belong to this newer generation of office-based or minimally invasive options. They are not a cure for BPH, and they are not right for everyone; candidacy depends on prostate size, shape, symptom severity, and overall health, which is why an in-person evaluation matters.
How Does UroLift (Prostatic Urethral Lift) Work?
UroLift is a prostatic urethral lift. Rather than cutting, heating, or removing prostate tissue, it uses small permanent implants, delivered through the urethra, to pull the enlarged lobes of the prostate apart and hold them out of the path of urine flow. The effect is mechanical: the channel is physically widened by retracting the obstructing tissue. UroLift was FDA-cleared in 2013, making it one of the earlier devices in this category.
Because it relies on pulling lateral (side) lobes aside, UroLift is generally best suited to men whose obstruction comes primarily from lateral-lobe enlargement rather than from a prominent median lobe (a lobe that projects into the bladder). One of its notable features, reported across the clinical literature, is that it typically preserves ejaculatory and erectile function, which is a priority for many men weighing their options. Because no tissue is removed or destroyed, the underlying prostate can continue to grow over time, and symptoms may return in some men, which is one reason durability and the possibility of retreatment are part of an honest discussion.
How Does Rezūm (Water Vapor Therapy) Work?
Rezūm is a convective water vapor therapy. During the procedure, a small amount of sterile steam is injected directly into the obstructing prostate tissue. The thermal energy carried by the vapor causes targeted cells to die, and over the following weeks to months the body reabsorbs that treated tissue, reducing the size of the obstruction and easing symptoms. Rezūm was FDA-cleared in 2015.
Unlike a purely mechanical lift, Rezūm actually reduces tissue volume, which means it can be considered across a broader range of prostate sizes and, importantly, can be used to treat a median lobe in appropriately selected patients. Because the effect depends on the body gradually reabsorbing treated tissue, the full symptom improvement is not immediate; it develops over a period of weeks. Men often use a catheter for a short time after the procedure while swelling settles. As with any tissue-reducing therapy, results vary between individuals, symptoms can persist or recur over the longer term, and retreatment or a different approach remains possible.
How Does iTind (Temporary Implant) Work?
iTind stands for temporary implantable nitinol device. It is a device that is placed in the prostatic urethra and bladder neck, where it gently expands over several days, typically five to seven, applying pressure that reshapes the tissue and creates channels for urine to flow more freely. Crucially, the device is then removed; nothing is left permanently inside the body. iTind was authorized in the United States through the FDA's De Novo pathway in 2020, a route used for novel low-to-moderate-risk devices without an existing equivalent.
Because iTind works by remodeling the bladder neck and prostatic urethra rather than removing tissue, it is often considered for men with a tight bladder neck and a suitable prostate configuration. The temporary nature appeals to some patients because there is no permanent implant and no tissue is heated or cut. As the FDA classification describes, the device is intended to increase prostatic urethral patency by widening the prostatic opening. Like the other MIST options, it is not a cure, its durability continues to be studied, and symptoms can recur, in which case further treatment may be discussed.
How Do the Three Compare on Prostate Anatomy?
Anatomy is often the single most important factor in matching a man to a procedure. UroLift, by lifting lobes apart, tends to suit lateral-lobe obstruction and is generally not the first choice when a large median lobe is the main problem. Rezūm, because it reduces tissue by vapor across a range of sizes, can address a wider variety of anatomies and can be applied to a median lobe in selected patients. iTind, which reshapes the bladder neck, is frequently considered when the bladder neck is tight and the prostate is not very large.
No single option is superior in the abstract, and none is "the best BPH procedure" for everyone; each is a tool that fits a particular pattern. Very large prostates, for example, may be better served by a tissue-removing operation rather than any of these three. This is why imaging and examination come before any recommendation: the shape and size of your prostate, the presence or absence of a median lobe, bladder function, and your symptoms together determine which options are even reasonable to consider.
What Does Recovery Look Like With Each Option?
All three are designed to be less invasive than traditional surgery, and many men return to normal activities relatively quickly, but recovery is not identical across the three, and individual experiences differ. UroLift, because it does not rely on tissue dying and being reabsorbed, can produce comparatively prompt symptom relief for suitable candidates, and some men avoid a catheter, though this depends on the individual. Rezūm often involves a short period of catheter use while post-procedure swelling settles, and because the tissue is reabsorbed gradually, symptom improvement builds over subsequent weeks rather than appearing at once.
iTind involves wearing the device for several days before it is removed, after which symptoms are reassessed. Temporary urinary symptoms, some blood in the urine, urgency, or discomfort can occur after any of these procedures as the area settles. The clinic's documented one-stop, same-day model means initial consultation, examination, and diagnostic assessment can often occur in a single visit, which can help international patients plan efficiently, though the treatment plan itself is individualized and no timeline can be promised in advance.
How Durable Are the Results, and Can Symptoms Recur?
Durability is one of the most important and most honestly complicated parts of this comparison. Because BPH is a progressive condition and the prostate can keep growing, none of these procedures stops the underlying process, and the benefits of any MIST option can diminish over time for some men. Published comparisons of these therapies show meaningful improvements in symptom scores and urinary flow, but they also document that a proportion of patients need retreatment, whether a repeat of the same procedure, a different MIST, medication, or a more definitive operation later.
This is not a reason to avoid these procedures; it is a reason to enter them with realistic expectations. A durable, satisfactory result for one man does not guarantee the same for another, and the possibility of recurrence and retreatment should be part of the decision from the start. During follow-up, a urologist reassesses symptoms and flow and discusses next steps if the benefit fades. Framing these treatments as symptom management rather than a permanent fix keeps expectations aligned with what the evidence actually supports.
Do These Procedures Preserve Sexual Function?
Preservation of sexual function is a major reason many men consider MIST options over traditional surgery, which more often affects ejaculation. Contemporary reviews of minimally invasive BPH treatments report that erectile and ejaculatory function are generally well preserved across UroLift, Rezūm, and iTind, which distinguishes them from procedures that remove larger amounts of tissue. UroLift in particular is frequently highlighted for preserving ejaculatory function because it does not cut or destroy tissue.
That said, "generally preserved" is not the same as "guaranteed," and any prostate procedure carries some risk of temporary or, less commonly, lasting effects on urinary or sexual function. Individual outcomes depend on your anatomy, baseline function, and the specific procedure. An honest consultation should cover the realistic likelihood of preserving function for your situation, rather than a blanket promise. If maintaining ejaculatory function is a high priority for you, say so clearly, because it can influence which option is most appropriate.
How Does Straight Urology Clinic Approach the Choice?
Straight Urology Clinic lists UroLift, Rezūm, and iTind among the minimally invasive options it discusses, and the choice among them is made after examination, not before. The clinic's stated philosophy is to listen first and explain every option clearly, which fits the reality of BPH care: the right procedure depends on the size and shape of your prostate, whether a median lobe is involved, your bladder function, your symptoms, and your own priorities around recovery and sexual function. Dr. Donghyun Lee is a urologist certified by Korea's Ministry of Health and Welfare (MOHW).
The clinic's one-stop, same-day model allows consultation, examination, and diagnostic assessment to be combined efficiently in many cases, which can be helpful for patients traveling from abroad. Candidacy for any procedure is determined by that in-person evaluation, and some men may be better served by medication, watchful waiting, or a more definitive operation. You can learn more about the clinic and its approach on the Straight Urology Clinic website, and international patients can begin an inquiry through the contact page. The clinic is located near Ahyeon Station on Seoul Metro Line 2.
What Are the Honest Limitations to Keep in Mind?
None of these three procedures is a cure for BPH, and none can be promised to work permanently. Each relieves obstruction in a different way, but the prostate can continue to change over time, symptoms can persist or return, and retreatment is possible. Each also carries potential side effects, including temporary urinary symptoms, blood in the urine, urgency, discomfort, or, less commonly, effects on urinary or sexual function. These are generally less pronounced than with more invasive surgery, but they are real and worth discussing.
Anatomy sets hard limits: a procedure that suits one prostate may be inappropriate for another, and a very large gland may fall outside what these office-based options can effectively treat. Published outcomes reflect averages across studied populations, not a prediction for any single person. The most reliable path is a thorough evaluation with a qualified urologist who can explain which options are realistic for your anatomy and symptoms, what each can and cannot achieve, and how the risks and benefits weigh against alternatives such as medication or more definitive surgery.
The Bottom Line
- UroLift (FDA-cleared 2013) lifts obstructing lobes aside with permanent implants and generally suits lateral-lobe enlargement while preserving sexual function.
- Rezūm (FDA-cleared 2015) uses water vapor to shrink tissue, can address various sizes including a median lobe, and improves symptoms gradually as tissue is reabsorbed.
- iTind (FDA De Novo, 2020) temporarily reshapes the bladder neck and prostatic urethra over several days and is then removed, often considered for a tight bladder neck.
- None of the three cures BPH; benefits and durability vary, symptoms can recur, retreatment is possible, and side effects exist.
- The right option, if any, depends on prostate size and shape, symptoms, and priorities, and is determined by an in-person evaluation.
Frequently Asked Questions
What is the main difference between UroLift, Rezūm, and iTind?
UroLift mechanically lifts and holds enlarged prostate lobes out of the way with small permanent implants, Rezūm uses water vapor to shrink obstructing tissue that the body then reabsorbs, and iTind temporarily reshapes the bladder neck and prostatic urethra before being removed. They work through different mechanisms and suit different prostate anatomies, which is why examination guides the choice.
Which procedure is right for me?
There is no single best procedure for everyone. The appropriate option depends on your prostate size and shape, whether a median lobe is involved, your bladder function, your symptoms, and your priorities around recovery and sexual function. A urologist determines candidacy through an in-person examination and imaging rather than from symptoms alone.
Do these procedures cure an enlarged prostate?
No. UroLift, Rezūm, and iTind relieve urinary symptoms but do not cure BPH or stop the prostate from changing over time. Benefits and durability vary between individuals, symptoms can persist or recur, and retreatment with the same or a different approach may be needed later.
Will I keep my sexual function after treatment?
Contemporary reviews report that erectile and ejaculatory function are generally well preserved with these minimally invasive options, and UroLift is often noted for preserving ejaculation. However, no outcome is guaranteed, and any prostate procedure carries some risk. Discuss your priorities with your urologist so they can factor them into the recommendation.
What is recovery like?
Recovery is generally quicker than with traditional surgery, but it differs by procedure and by individual. Some men use a catheter for a short time, temporary urinary symptoms or blood in the urine can occur, and with Rezūm the improvement builds over weeks as tissue is reabsorbed. Your urologist will explain what to expect for your specific situation.
Are UroLift, Rezūm, and iTind FDA-cleared?
Yes. UroLift was FDA-cleared in 2013, Rezūm in 2015, and iTind was authorized through the FDA's De Novo pathway in 2020. FDA clearance or authorization means the device met the applicable regulatory standard for marketing in the United States; it does not guarantee a particular result for any individual patient.
This article is for general educational purposes and is not a self-diagnosis tool or a substitute for individualized medical advice. Candidacy, treatment selection, and expected outcomes for BPH can only be determined through an in-person consultation with a qualified urologist. Always discuss your specific situation with a licensed provider.
More Articles
Continue reading clinical insights and recovery guides from Straight Urology Clinic.
Who Is a Candidate for REZUM Water Vapor Therapy
Learn who may be a candidate for REZUM Water Vapor Therapy, key eligibility factors, benefits, and what to expect. Explore your treatment options today.
Learn More
Why a Urologist's Case Volume Should Matter to You
Surgical case volume is linked to a urologist's experience but never guarantees your outcome. Learn to read reported urology procedure counts critically.
Learn More
What AUA Membership Means for Your Urologist Choice
Learn what American Urological Association Full Membership actually means, why it is not a board certification, and how to verify an overseas urologist.
Learn More